NIA-AA Symposium: Enabling Precision Medicine for Alzheimer's Disease Through Open Science

 

Overview

This symposium will feature an array of translational research programs that integrate computational and experimental approaches to:

  1. Discover novel, disease-relevant targets and biomarkers.
  2. Develop next-generation animal models and target enabling tools.
  3. Support the development of new candidate therapeutics for a diverse portfolio of targets.
  4. Advance data-driven drug repositioning and combination therapy development.

The featured programs will include:

Agenda

View the agenda.

Target Audience

Academic, biotech and pharmaceutical industry researchers with interest in target and biomarker discovery, preclinical and clinical drug development; computational biologists; data scientists; and open science advocates.

Join ISTAART and Attend AAIC Online at No Cost!

Not an ISTAART member? Select the ISTAART + AAIC Bundle during registration. You’ll receive year-long ISTAART membership and all its benefits, including global networking opportunities, exclusive webinars, career resources and much more — plus free AAIC registration.


JOIN NOW AND REGISTER

Join the Conversation #AAIC21

Follow

Exhibitors

Exhibitors

Sponsors

Sponsorship

> 1200px
lg
> 992px
md
> 768px
sm
< 767px
xs